DDB1通过增强PAK1介导的有氧糖解促进垂体腺瘤的进展
Shuangwu Yang1, Yuefei Zhou1, Yunchao Yuan1
1Department of Neurosurgery, Xijing Hospital, the Fourth Military Medical University, Xi'an, 710032, Shaanxi, China.
通过增强PAK1介导的有氧糖解,DNA损伤结合蛋白1 (DDB1) 促进垂体腺瘤生长和益生素分泌. 准DDB1/PAK1轴为垂体腺瘤提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- DNA损伤结合蛋白1 (DDB1) 涉及到各种癌症.
- 在垂体腺瘤 (PA) 代谢中DDB1的作用尚不清楚.
研究的目的:
- 研究DDB1在垂体腺瘤扩散,分泌和代谢中的作用.
- 阐明涉及DDB1/PAK1轴的潜在分子机制.
主要方法:
- 对PA组织中DDB1表达的分析.
- 在体外研究涉及DDB1在PA细胞中被淘汰/过度表达.
- 对于DDB1和PAK1的相互作用,共免疫沉 (Co-IP) 和双免疫光.
- 在体内异种移植的小鼠模型.
主要成果:
- DDB1在PA组织中升级调节,促进PA细胞增殖,细胞循环进展,益生素 (PRL) 分泌和有氧糖解.
- DDB1与PAK1相互作用,这种相互作用对DDB1的影响至关重要.
- 抑制PAK1或抑制有氧糖解逆转了DDB1诱导的影响.
- 在体内,DDB1的过度表达促进了瘤的生长,这被PAK1的淘汰赛所废除.
结论:
- DDB1通过增强PAK1介导的有氧糖解促进垂体腺瘤生长和PRL分泌.
- DDB1/PAK1轴代表了对 pituitary adenoma 治疗的潜在治疗点.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
07:00Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
Published on: August 23, 2018
相关概念视频
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
